Cargando…
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures
An emerging cellular immunotherapy for cancer is based on the cytolytic activity of natural killer (NK) cells against a wide range of tumors. Although in vitro activation, or “priming,” of NK cells by exposure to pro-inflammatory cytokines, such as interleukin (IL)-2, has been extensively studied, t...
Autores principales: | Sabry, May, Zubiak, Agnieszka, Hood, Simon P., Simmonds, Poppy, Arellano-Ballestero, Helena, Cournoyer, Eily, Mashar, Meghavi, Pockley, A. Graham, Lowdell, Mark W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594622/ https://www.ncbi.nlm.nih.gov/pubmed/31242243 http://dx.doi.org/10.1371/journal.pone.0218674 |
Ejemplares similares
-
A Killer Disarmed: Natural Killer Cell Impairment in Myelodysplastic Syndrome
por: Arellano-Ballestero, Helena, et al.
Publicado: (2023) -
Tumor-Primed NK Cells: Waiting for the Green Light
por: Sabry, May, et al.
Publicado: (2013) -
Killers at the crossroads: The use of innate immune cells in adoptive cellular therapy of cancer
por: Sabry, May, et al.
Publicado: (2020) -
Postgraduate radiology education: what has Covid-19 changed?
por: Nanapragasam, Andrew, et al.
Publicado: (2021) -
Interventional radiology training: where will technology take us?
por: Mashar, Meghavi, et al.
Publicado: (2019)